Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities

Documenti analoghi

• Beyond Population‐Level Targets for Drug Concentrations: Precision Dosing Needs Individual‐Level Targets that Include Superior Biomarkers of Drug Responses
  di: Thomas M. Polasek, et al.
  Pubblicazione: (2024)
• From Challenge to Opportunity: How Shwachman–Diamond Syndrome Became a Promising Target for Therapy Development
  di: Eszter S. Hars, et al.
  Pubblicazione: (2024)
• Interchanging Biosimilars Using Proteomics
  di: Piet H. van der Graaf, et al.
  Pubblicazione: (2025)
• Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
  di: Qi Liu, et al.
  Pubblicazione: (2024)
• Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability
  di: Sarah K. Emond, et al.
  Pubblicazione: (2025)